{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260608352333/en/U.S.-FDA-Accepts-Takedas-Application-for-Intravenous-ENTYVIO%C2%AE-vedolizumab-in-Pediatric-Ulcerative-Colitis-and-Crohns-Disease", "message": "News view counter 789815 successfully enlarged"}